CARLSON CAPITAL L P - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 26 filers reported holding LANTERN PHARMA INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
CARLSON CAPITAL L P ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$323,950
-39.5%
95,0000.0%0.02%
-45.7%
Q2 2023$535,800
-11.2%
95,000
-23.9%
0.05%
-19.3%
Q1 2023$603,267
-27.6%
124,900
-9.5%
0.06%
-10.9%
Q4 2022$833,520
+3.8%
138,000
-17.9%
0.06%
+4.9%
Q3 2022$803,000
-17.3%
168,000
-1.2%
0.06%
-9.0%
Q2 2022$971,000
-18.8%
170,000
+1.6%
0.07%
-18.3%
Q1 2022$1,196,000
+19.8%
167,300
+33.8%
0.08%
+43.9%
Q4 2021$998,000125,0000.06%
Other shareholders
LANTERN PHARMA INC shareholders Q2 2023
NameSharesValueWeighting ↓
SANDERS MORRIS HARRIS LLC 384,228$2,747,0000.54%
CM Management, LLC 33,765$241,0000.20%
WOLFF WIESE MAGANA LLC 36,155$259,0000.17%
Redmond Asset Management, LLC 49,793$356,0000.11%
CARLSON CAPITAL L P 167,300$1,196,0000.08%
NewEdge Advisors, LLC 169,771$1,214,0000.02%
Sigma Planning Corp 17,600$126,0000.00%
Spire Wealth Management 4,050$29,0000.00%
WELLS FARGO & COMPANY/MN 3,558$25,0000.00%
NORTHERN TRUST CORP 12,629$90,0000.00%
View complete list of LANTERN PHARMA INC shareholders